Supplemental Figure 10 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer

• DOI: 10.1158/2326-6066.27026579.v1
• Publication Date: 2024-09-16T09:51:44Z
• Authors: Apostolia M. Tsim...; Kerstin Guenther; Borje S. Andersson; Regina Mendrzyk; Amir Alpert; Claudia Wagner; Anna Nowak; Katrin Aslan; Arun Satelli; Fabian Richter; Sabrina Kuttruff-...; Oliver Schoor; Jens Fritsche; Zoe Coughlin; Ali S. Mohamed; Kerry Sieger; Becky Norris; Rita Ort; Jennifer Beck; Henry Hiep. Vo; Franziska Hoffgaard; Manuel Ruh; Linus Backert; Ignacio I. Wistuba; David Fuhrmann; Nuhad K. Ibrahim; Van Karlyle. Morris; Bryan K. Kee; Daniel M. Halperin; Graciela M. Nogue...; Partow Kebriaei; Elizabeth J. Shpall; David Vining; Patrick Hwu; Harpreet Singh-Ja...; Carsten Reinhardt; Cedrik M. Britten; Norbert Hilf; Toni Weinschenk; Dominik Maurer; Steffen Walter
• Keywords: Cancer Therapy

<p>Supplemental Figure 10</p>